BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2008
View Archived Issues
BioMimetic Therapeutics responds to FDA communication on Regranex safety review
Read More
New agents for treating neurological disorders disclosed in recent patents
Read More
Cysteine protease inhibitors reduce beta-amyloid, improve memory in Alzheimer's model
Read More
SAHA enhances anti-CD3 conditioning for allogeneic hematopoietic cell transplant
Read More
Conor and Cordis initiate RES-ELUTION clinical trial of sirolimus-eluting coronary stent
Read More
ARCA Discovery changes name to ARCA biopharma and plans to file NDA for bucindolol
Read More
Merck & Co. places on hold further patient enrollment in ACHIEVE study of Cordaptive
Read More
AstraZeneca stops JUPITER study of Crestor early due to unequivocal evidence of benefit
Read More
Crucell initiates phase II clinical trial of rabies monoclonal antibody
Read More
Acusphere licenses hydrophobic drug delivery system and AI-850 to Cephalon
Read More
DUSA completes enrollment in phase IIb trial of Levulan photodynamic therapy for acne
Read More
MediciNova initiates phase II clinical trial of MN-221 in asthma
Read More
DSMB supports continuation of Genta's phase III AGENDA trial of Genasense in melanoma
Read More
Recent patents describe new treatment options for endocrine disorders
Read More
AnGes files NDA in Japan for Collategene in critical limb ischemia
Read More
Novel peptide shows cardiac unloading properties without causing hypotension
Read More
InterMune reports top-line phase Ib ITMN-191 results in HCV
Read More
Relistor receives Canadian approval for opioid-induced constipation
Read More
Vivus and FDA agree on safety study and SPA for phase III trials of Luramist for HSDD
Read More
Avant reports positive results from phase II clinical trial of typhoid fever vaccine Ty-800
Read More
BAY-58-2667 shows promise in acute decompensated heart failure patients
Read More
Lysteria monocytogenes-based vaccine induces tumor regression in murine model of prostate cancer
Read More
Taranabant study shows weight loss, metabolic benefits after one year
Read More
Novel antiinfective agents reported in recent Saitama University and Actelion patents
Read More
TAK-475 development for hypercholesterolemia discontinued
Read More